The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Nanoparticle approaches against bacterial infections
Open accessAbstract
Despite the wide success of antibiotics, the treatment of bacterial infections still faces significant challenges, particularly the emergence of antibiotic resistance. As a result, nanoparticle drug delivery platforms including liposomes, polymeric nanoparticles, dendrimers, and various inorganic nanoparticles have been increasingly exploited to enhance the therapeutic effectiveness of existing antibiotics. This review focuses on areas where nanoparticle approaches hold significant potential to advance the treatment of bacterial infections. These areas include targeted antibiotic delivery, environmentally responsive antibiotic delivery, combinatorial antibiotic delivery, nanoparticle‐enabled antibacterial vaccination, and nanoparticle‐based bacterial detection. In each area we highlight the innovative antimicrobial nanoparticle platforms and review their progress made against bacterial infections.WIREs Nanomed Nanobiotechnol 2014, 6:532–547. doi: 10.1002/wnan.1282 This article is categorized under:Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
The use of nanocrystals in biological detection
Alivisatos, P. (2004) · Nature Biotechnology · doi:10.1038/nbt927 · Cited by 3,008
Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., & Pittet, D. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61458-4 · Cited by 2,514
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
Katz, E., & Willner, I. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200400651 · Cited by 2,450
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Self-citationThe challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Cited by
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 881
Shaikh, S., Nazam, N., Rizvi, S. M. D., Ahmad, K., Baig, M. H., Lee, E. J., & Choi, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102468 · Cited by 507
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Biomedical applications of nanotechnology
Ramos, A. P., Cruz, M. A. E., Tovani, C. B., & Ciancaglini, P. (2017) · Biophysical Reviews · doi:10.1007/s12551-016-0246-2 · Cited by 413
Carbon Dot-Based Platform for Simultaneous Bacterial Distinguishment and Antibacterial Applications
Yang, J., Zhang, X., Ma, Y.-H., Gao, G., Chen, X., Jia, H.-R., Li, Y.-H., Chen, Z., & Wu, F.-G. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10398 · Cited by 409
Carbon quantum dots: Preparation, optical properties, and biomedical applications
Yang, H.-L., Bai, L.-F., Geng, Z.-R., Chen, H., Xu, L.-T., Xie, Y.-C., Wang, D.-J., Gu, H.-W., & Wang, X.-M. (2023) · Materials Today Advances · doi:10.1016/j.mtadv.2023.100376 · Cited by 409
Application of Light Scattering Techniques to Nanoparticle Characterization and Development
Carvalho, P. M., Felício, M. R., Santos, N. C., Gonçalves, S., & Domingues, M. M. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00237 · Cited by 402
Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy
Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399
Nanoparticle-based local antimicrobial drug delivery
Gao, W., Chen, Y., Zhang, Y., Zhang, Q., & Zhang, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.015 · Cited by 396
Self-citationNisar, P., Ali, N., Rahman, L., Ali, M., & Shinwari, Z. K. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01717-7 · Cited by 362
Antibiotic resistance breakers: current approaches and future directions
Laws, M., Shaaban, A., & Rahman, K. M. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz014 · Cited by 356
Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery
Gao, W., Zhang, Y., Zhang, Q., & Zhang, L. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1583-9 · Cited by 346
Self-citationAntimicrobial Metal Nanomaterials: From Passive to Stimuli‐Activated Applications
Cheeseman, S., Christofferson, A. J., Kariuki, R., Cozzolino, D., Daeneke, T., Crawford, R. J., Truong, V. K., Chapman, J., & Elbourne, A. (2020) · Advanced Science · doi:10.1002/advs.201902913 · Cited by 337
Biomimetic Nanotechnology toward Personalized Vaccines
Zhou, J., Kroll, A. V., Holay, M., Fang, R. H., & Zhang, L. (2020) · Advanced Materials · doi:10.1002/adma.201901255 · Cited by 328
Self-citationThakur, N., Thakur, N., Kumar, A., Thakur, V. K., Kalia, S., Arya, V., Kumar, A., Kumar, S., & Kyzas, G. Z. (2024) · Science of The Total Environment · doi:10.1016/j.scitotenv.2023.169815 · Cited by 272
RetractedInfection microenvironment-related antibacterial nanotherapeutic strategies
Wang, Z., Liu, X., Duan, Y., & Huang, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121249 · Cited by 268
Recent advances in targeted antibacterial therapy basing on nanomaterials
Geng, Z., Cao, Z., & Liu, J. (2023) · Exploration · doi:10.1002/exp.20210117 · Cited by 262
Nanotechnology Formulations for Antibacterial Free Fatty Acids and Monoglycerides
Jackman, J., Yoon, B., Li, D., & Cho, N.-J. (2016) · Molecules · doi:10.3390/molecules21030305 · Cited by 109
Arunachalam, K., Pandurangan, P., Shi, C., & Lagoa, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020310 · Cited by 48
“The mechanism of bacterial growth and biofilm inhibition by NPs depends on several factors, such as surface area, surface interactions, NPs stability, NPs shape, and drug loading and releasing characteristics [148].”
BackgroundOvotransferrin—Multifunctional protein: Structure, bioactivity, and industrial potential
Fijałkowski, P., Pryshchepa, O., van Eldik, R., & Pomastowski, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144810 · Cited by 10
Metadata
- Authors
- Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2014-07-15
- Volume
- 6
- Issue
- 6
- Pages
- 532-547
- ISSN
- 1939-0041 (ISSN-L)
- 1939-5116
- OpenAlex
- W1698551943
- Cited by
- 347
- References
- 157
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.